Bonek, R.; Guenter, W.; Jałowiński, R.; Karbicka, A.; Litwin, A.; Maciejowski, M.; Zajdel, R.; Petit, V.; Rejdak, K.
JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Treatment-Naïve Patients. J. Clin. Med. 2020, 9, 3867.
https://doi.org/10.3390/jcm9123867
AMA Style
Bonek R, Guenter W, Jałowiński R, Karbicka A, Litwin A, Maciejowski M, Zajdel R, Petit V, Rejdak K.
JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Treatment-Naïve Patients. Journal of Clinical Medicine. 2020; 9(12):3867.
https://doi.org/10.3390/jcm9123867
Chicago/Turabian Style
Bonek, Robert, Wojciech Guenter, Robert Jałowiński, Anna Karbicka, Anna Litwin, Maciej Maciejowski, Radosław Zajdel, Veronique Petit, and Konrad Rejdak.
2020. "JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Treatment-Naïve Patients" Journal of Clinical Medicine 9, no. 12: 3867.
https://doi.org/10.3390/jcm9123867
APA Style
Bonek, R., Guenter, W., Jałowiński, R., Karbicka, A., Litwin, A., Maciejowski, M., Zajdel, R., Petit, V., & Rejdak, K.
(2020). JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Treatment-Naïve Patients. Journal of Clinical Medicine, 9(12), 3867.
https://doi.org/10.3390/jcm9123867